… by treatment with rivaroxaban versus warfarin. There is no proven reversal strategy for
rivaroxaban or for any of the direct factor Xa inhibitors or dabigatran, although anticoagulation …

… Consecutive patients that underwent cryoballoon ablation of atrial fibrillation at our institution
over the past 3 years were evaluated via retrospective chart review. Patients were stratified …

… [15] showed that rivaroxaban had a significantly higher risk of bleeding than dabigatran, …
the efficacy and safety between rivaroxaban and dabigatran in patients with atrial fibrillation (AF) …

… received a new prescription for apixaban, dabigatran, rivaroxaban, or warfarin after the AF
… to any oral anticoagulants (apixaban, dabigatran, rivaroxaban, or warfarin) within 180 days …

… RB was a 77-year-old white male with a pertinent history of atrial fibrillation with rapid
ventricular rate on dabigatran for stroke prophylaxis, sick sinus syndrome s/p automated …

… dabigatran and warfarin users (71.8% and 53.3%; p < 0.001). In the current study, the
persistence rates for rivaroxaban … The hazard ratio suggests that patients receiving rivaroxaban …

… with atrial fibrillation treated in practice, the incidences of stroke and bleeding with dabigatran
… The possible relationship between dabigatran and myocardial infarction warrants further …

… : Dabigatran and rivaroxaban have been approved by the US FDA to reduce the risk of
stroke and systemic embolism in non-valvular atrial fibrillation (… with rivaroxaban experienced …

… (rivaroxaban, dabigatran, and apixaban) compared with VKAs (eg warfarin), in patients with
nonvalvular atrial fibrillation (… results for rivaroxaban versus VKAs, 79 for dabigatran versus …

… : apixaban 2.5 mg, dabigatran 110 mg, and rivaroxaban 15 mg. To ensure the … atrial fibrillation,
we excluded patients with previous hospital diagnoses indicating valvular atrial fibrillation …